Molecular 1
Molecular 1
Introduction
                                                                       C-to-U Editing
Although completion of the Human Genome Project
represents a milestone in modern biology, it has
become increasingly apparent that the primary nucle-
                                                                       Apolipoprotein B
otide sequence of human genetic material cannot be                     The first editing event identified in human RNA was a
used to predict accurately the nucleotide sequences of                 single C-to-U conversion in mRNA transcripts en-
many expressed ribonucleic acids (RNAs) or the                         coding apolipoprotein B (apoB; Powell et al., 1987).
amino acid sequences of their encoded protein                          Two distinct proteins, apoB-100 and apoB-48, can be
products. RNAs encoded by most eukaryotic genes                        produced from the apolipoprotein B (APOB) gene
can undergo different posttranscriptional RNA pro-                     through a tissue-specific C-to-U editing event at
cessing events (splicing, capping, polyadenylation),                   cytidine 6666 in APOB transcripts, which converts a
which are required to convert RNA precursors into                      genomically encoded glutamine codon (CAA) to an
mature RNA transcripts. During the mid-1980s, an                       in-frame stop codon (UAA; Figure 2a). This single-
additional RNA processing term, called ‘RNA                            base modification allows the production of apoB-48 in
editing’, was coined to describe a genetic phenomenon                  the small intestine; this apoB variant of 241 kilo-
in which uridine residues were inserted and deleted                    daltons (kDa) is a component of the triglyceride-rich
from the mitochondrial RNAs of kinetoplastid
protozoa (Benne et al., 1986). Since then, the term
RNA editing has been used to describe numerous                                NH2                                                              O
cellular processes resulting in the modification of RNA                                                H2O                  NH3
sequences differing from that designated by their
deoxyribonucleic acid (DNA) or RNA templates in                                       N                                                                NH
organisms as diverse as bacteria, protozoa, plants and
humans. These processes, which affect messenger                                   N           O                                                N            O
RNAs (mRNAs), transfer RNAs (tRNAs) and ribo-
somal RNAs, can alter the structure, stability,                               R                                                            R
translation efficiency, splicing patterns and coding                           Cytidine                                                     Uridine
potential of the modified transcripts, thereby affecting
almost all aspects of cellular RNA function. (See RNA
                                                                                      NH2                                                          O
Processing; Splicing of pre-mRNA.)                                                                    H2O                  NH3
   So far, the identification of editing events in human                    N                                                         N
RNAs has been limited largely to nucleoside modifi-                                                N                                                     NH
cations in which specific cytidine residues are
posttranscriptionally converted to uridine moieties                           N           N
                                                                                                                                       N
                                                                                                                                                   N
(C-to-U editing) or in which specific adenosines are
                                                                          R                                                        R
converted to inosines (A-to-I editing; Figure 1). C-to-
U and A-to-I editing events are mediated by distinct                           Adenosine                                                   Inosine
mechanisms that require specific regulatory sequence
                                                                       Figure 1 RNA editing by hydrolytic deamination. RNA editing
elements and cellular factors, but both types of editing
                                                                       events involving the conversion of cytidine to uridine (C to U) and
represent RNA processing events by which several                       adenosine to inosine (A to I) occur as a result of hydrolytic
RNA and protein isoforms can be generated from a                       deamination at the C4 and C6 positions of the pyrimidine and
single genomic locus to increase the coding potential of               purine bases, respectively, with the oxygen of water acting as
the human genome.                                                      the nucleophile. R: ribose.
                                 ENCYCLOPEDIA OF LIFE SCIENCES & 2005, John Wiley & Sons, Ltd. www.els.net                                                      1
    mRNA Editing
                             APOB gene
                             ATG                                                                      CAA                      TAA
                                                                                                                  Transcription
                                                          Liver                           Intestine                  Splicing
                            APOB mRNA                                                                            Polyadenylation
                                                                                                                                      Nucleus
                            ATG                 CAA                   UAA      ATG               CAA (GIn)               UAA
                            5⬘                                          (A)n 5⬘                                                (A)n
                            Nonedited mRNA                                         Nonedited
                                                                                    mRNA                             C-to-U
                                                                                                                     editing
                                                                                                                                      Cytoplasm
                                                                              5⬘
                                                                                   Edited mRNA
                                                                                                                   Translation
                            apoB protein
                               1                                      4536                  1               2152
                                         Lipoprotein   LDL receptor                                Lipoprotein
                            NH2           assembly       binding
                                                                        COOH          NH2           assembly
                                                                                                                 COOH
                   (a)                         apoB-100                                         apoB-48
Figure 2 Biosynthetic pathway for the tissue-specific production of apoB isoforms through site-specific C-to-U editing. (a) Organization
of the APOB gene, with the start (ATG), stop (TAA) and edited glutamine (CAA) codons indicated in exons 1, 26 and 29, respectively;
the cytidine residue in the nonedited intestinal transcript and the uridine residue in the edited mRNA, after the C-to-U modification, are
underlined. The structures of the apoB-100 and apoB-48 protein isoforms are shown below, with their principal functional domains and
corresponding amino acid lengths. (A)n, poly(A) tail. (b) The tripartite sequence motif required for the C-to-U editing of APOB transcripts
(efficiency element, spacer, mooring sequence), with the edited cytidine residue indicated in white on black lettering.
chylomicrons that deliver dietary lipids to the tissues.                     regulatory sequence surrounding the edited cytidine
By contrast, in the liver the unmodified (non-                                residue in APOB RNAs, with essential elements
edited) RNA encodes apoB-100, an integral 512-kDa                            referred to as the mooring sequence, enhancer and
component of lipoprotein complexes involved in the                           spacer region (Figure 2b; Backus and Smith, 1992;
transport of dietary cholesterol (Davidson and                               Shah et al., 1991).
Shelness, 2000). This C-to-U conversion emphasizes                              The biochemical characterization and purification
the potential power of RNA editing, because such a                           of enterocyte extracts showed that the editing of APOB
subtle RNA processing event can generate two distinct                        transcripts requires the actions of a multiprotein
isoforms of apoB protein that have unique roles in                           complex, referred to as the ‘editosome’, that contains
the synthesis, metabolism and transport of plasma                            a 27-kDa catalytic cytidine deaminase, apobec-1 and
lipoproteins. (See Apolipoprotein Gene Structure and                         several auxiliary proteins (Teng et al., 1993). Apobec-1
Function.)                                                                   itself has a low affinity for APOB RNA in vitro and
   Analyses of nuclear and cytoplasmic RNAs have                             cannot function in the absence of additional RNA-
shown that the C-to-U modification of APOB tran-                              binding factors (Anant et al., 1995). The auxiliary
scripts is a nuclear event that can be initiated at the                      protein apobec-1 complementation factor (ACF) has
time of polyadenylation and is essentially complete by                       been shown to bind specifically to the mooring
the time that the precursor mRNA (pre-mRNA) has                              sequence, interact with apobec-1 and promote the
been fully processed (Lau et al., 1991; Figure 2a). The                      C-to-U editing of APOB transcripts in the presence of
development of an in vitro assay system using                                apobec-1 (Mehta and Driscoll, 2002; Mehta et al.,
enterocyte postmicrosomal cytoplasmic extracts and                           2000), thus defining the minimal holoenzyme required
radiolabeled APOB RNA substrates allowed                                     for APOB modification.
investigators to determine that the mechanism respon-
sible for the C-to-U editing of APOB transcripts                             Neurofibromin 1
involves hydrolytic deamination at the C4 position of
cytidine (Figure 1; Hodges et al., 1991; Driscoll et al.,                    In addition to APOB transcripts, a similar C-to-U
1989). This RNA modification requires a tripartite                            conversion has been observed in transcripts produced
2
                                                                                                    mRNA Editing
from neurofibromin 1 (NF1), a tumor suppressor gene         deficiency, hyper-IgM syndrome, characterized by
involved in neurofibromatosis type I (Skuse et al.,          normal or increased concentrations of IgM with an
1996). Neurofibromatosis type I (also known as von           absence of IgG, IgA and IgE, and a profound
Recklinghausen neurofibromatosis) is a complex here-         susceptibility to bacterial infections (Notarangelo
ditary syndrome resulting in several abnormalities that     et al., 1992). Whereas the role of apobec-1 is to edit
affect tissues derived from the embryonic neural crest,     APOB RNAs by site-specific cytidine deamination, the
including cutaneous and subcutaneous neurofibromas           function of AID is to potentiate changes in the
and malignancies of the central and peripheral nervous      sequences of immunoglobulin genes themselves. Al-
system (Goldberg et al., 1996). The editing of NF1,         though the mode of action for AID is completely
which was identified originally by using a computa-          unknown, accumulating data have suggested that AID
tionally based strategy to find RNAs containing a high       might act by either editing an RNA that encodes a key
degree of sequence conservation with the APOB editing       protein (e.g. an endonuclease), thereby initiating the
site (Skuse et al., 1996), results in the conversion of a   processes of CSR and SHM, or directly modifying the
genomically encoded arginine (CGA) codon to a stop          target DNA, with the induced lesion triggering an
(UGA) codon, thereby generating a truncated isoform         error-prone repair cascade (Martin et al., 2002).
of the NF1 protein. The physiological consequences of
this C-to-U conversion are not well understood, nor
are the roles that NF1 editing may have in the
pathogenesis of neurofibromatosis (Skuse and                 A-to-I Editing
Cappione, 1997). Notably, despite the sequence
similarity between the editing regions of APOB and          The conversion of adenosine to inosine by RNA
NF1 transcripts, apobec-1 does not seem to be               editing was first observed in yeast tRNAs (Grosjean
responsible for the modification of NF1 mRNAs                et al., 1996; Holley, 1965) but has since been identified
(Skuse et al., 1996), indicating that different trans-      in several viral RNA transcripts and cellular mRNA
acting factors may be involved in these two C-to-U          species (Emeson and Singh, 2001). A-to-I editing
modifications. (See Neurofibromatosis: Type I.)              is most often identified as an adenosine to guanosine
                                                            (A-to-G) discrepancy between genomic and comple-
                                                            mentary DNA (cDNA) sequences, owing to the
Immunoglobulin diversity                                    similar base-pairing properties of inosine and
                                                            guanosine during cDNA synthesis. A-to-I conversion
The diversity of immunoglobulin expression required         is catalyzed through hydrolytic deamination at the C6
for an effective immune response requires the gener-        position of the adenine ring (Figure 1; Polson et al.,
ation of numerous immunoglobulin genes by distinct          1991) and requires an extended region of double-
cellular processes, including the recombination of          stranded RNA in potential RNA substrates formed by
variable, diversity and joining segments (V(D)J             intramolecular base-pairing interactions between exon
recombination), somatic hypermutation (SHM) and             and intron sequences (Burns et al., 1997; Lomeli et al.,
class switch recombination (CSR; Honjo et al., 2002).       1994; Higuchi et al., 1993). (See RNA Secondary
After V(D)J gene rearrangement, mature B lympho-            Structure Prediction; RNA-binding Proteins: Regulation
cytes undergo a switch of immunoglobulin isotype            of mRNA Splicing, Export and Decay; tRNA.)
from immunoglobulin-m (IgM) to immunoglobulin-g                A family of adenosine deaminases that act on RNA
(IgG), immunoglobulin-e (IgE) or immunoglobulin-a           (ADARs) has been characterized extensively and is
(IgA) – a process that is mediated by CSR, which            responsible for catalyzing the site-specific A-to-I
changes the immunoglobulin heavy chain constant             conversion observed in numerous cellular mRNA
region (CH) gene from Cm to one of the other CH genes.      transcripts (Melcher et al., 1996; O’Connell et al.,
SHM introduces vast numbers of point mutations in           1995; Hough and Bass, 1994; Kim et al., 1994).
the immunoglobulin variable region gene, giving rise        Although only a few inosine-containing human tran-
to immunoglobulins with higher affinity. The process-        scripts have been described so far, the wide distribu-
es of CSR and SHM depend on the activity of                 tion of ADAR protein expression and the relatively
activation-induced cytidine deaminase (AID), a B-           high levels of inosine in mammalian brain mRNAs
cell-specific protein that has been proposed to function     (Paul and Bass, 1998) have suggested that numerous
by RNA editing on the basis of its sequence similarity      edited RNAs have yet to be identified. At least seven
to apobec-1 and other cytidine deaminases                   transcripts containing A-to-I editing events have been
(Muramatsu et al., 1999). (See Immunoglobulin Genes.)       identified that can change the amino acid coding
   Humans who are deficient in AID show a lack of            potential in human mRNAs; notably, transcripts
CSR and severely reduced SHM (Revy et al., 2000),           encoding the 2C subtype of the serotonin or
producing a rare autosomal recessive human immuno-          5-hydroxytryptamine (5-HT) receptor (5-HT2CR),
                                                                                                                   3
    mRNA Editing
the B-subunit of the a-amino-3-hydroxy-5-methyl-           To address the role of Q/R editing and subsequent
isoxazole-4-propionate (AMPA) subtype of the iono-         changes in the electrophysiological and ion-
tropic glutamate receptor (GluR-B) and the 5 subunit       permeation properties of heteromeric AMPA channels,
and the 6 subunit of the kainate subtype of the            Brusa et al. (1995) generated a genetically modified
ionotropic glutamate receptor (GluR-5 and GluR-6)          mouse strain incapable of editing GluR-B transcripts
undergo A-to-I modifications that change the amino          by selectively disrupting the RNA duplex region
acid coding potential of the mature mRNAs, thereby         required for Q/R site editing. Animals heterozygous
producing protein products with altered functional         for the targeted mutation were smaller than control
properties. A-to-I editing can also occur in noncoding     littermates at birth and expressed AMPA receptors
regions of human mRNA transcripts (Morse et al.,           with the expected increase in Ca2þ permeability in
2002) and in introns (Rueter et al., 1995, 1999; Higuchi   several brain regions. At roughly 2 weeks of age,
et al., 1993).                                             however, the mutant animals rapidly developed a
                                                           severely compromised phenotype, characterized by
Glutamate-gated ion channels                               spontaneous and recurrent seizures, and by progres-
                                                           sively agitated states and running fits. All of the
The first example of A-to-I editing for mammalian           heterozygous mutant animals died by postnatal day
mRNAs was observed in transcripts encoding                 20, indicating that Q/R site editing is essential for
glutamate-gated ion channels in the central nervous        normal brain function (Brusa et al., 1995).
system (CNS; Sommer et al., 1991). L-glutamate is the          In addition to Q/R site modification in GluR-B
principal excitatory neurotransmitter in the brain and     transcripts, a second RNA editing event converts an
activates cation-selective receptor channels involved in   arginine (AGA) to a glycine (IGA) codon in mRNAs
fast synaptic neurotransmission and in the induction       encoding the GluR-B, GluR-C and GluR-D AMPA
of long-term cellular changes associated with memory       receptor subunits. Introduction of this edited glycine
acquisition and learning (Nicoll and Malenka, 1999;        residue in heteromeric AMPA receptors results in an
Collingridge and Singer, 1990). Pharmacological and        increase in the rate of recovery from receptor
physiological studies have identified three distinct        desensitization and a tendency toward slower desensi-
subtypes of ionotropic glutamate receptor on the           tization rates (Lomeli et al., 1994). These properties
basis of the selective agonists N-methyl-D-aspartate       may be crucial for determining the excitability of a
(NMDA), AMPA and kainic acid. (See Glutamate               single postsynaptic site in response to repeated
Receptors.)                                                glutamate stimulation.
AMPA receptors                                             Kainate receptors
The AMPA subtype of glutamate receptor is involved         A second family of ionotropic glutamate receptors,
primarily in fast synaptic neurotransmission and is        which are selectively responsive to kainic and domoic
expressed widely throughout the CNS (Hollmann and          acid, can be generated by heteromeric assembly of the
Heinemann, 1994). Functional AMPA channels con-            subunits GluR-5, GluR-6, GluR-7 (Bettler et al., 1992;
sist of homomeric or heteromeric combinations of four      Sommer et al., 1992; Egebjerg et al., 1991) and KA-1 or
distinct subunits, GluR-A, GluR-B, GluR-C and              KA-2 (Herb et al., 1992; Sakimura et al., 1990). Like
GluR-D (Boulter et al., 1990; Keinanen et al., 1990;       AMPA receptors, kainate receptors are thought to be
Nakanishi et al., 1990; Sakimura et al., 1990). RNAs       involved in fast synaptic neurotransmission and are
encoding the GluR-B subunit undergo a site-specific         expressed widely in many regions of the brain
(Q/R site) modification that converts a genomically         (Seeburg, 1993). The electrophysiological and ion-
encoded glutamine codon (CAG) to an arginine codon         permeation properties of the GluR-5 and GluR-6
(CIG) in the second hydrophobic domain of the              subunits can be regulated by RNA editing processes
protein that is presumed to line the ion channel pore.     similar to those observed for AMPA receptor subunits
Heteromeric AMPA channels that contain the edited          (Egebjerg and Heinemann, 1993; Kohler et al., 1993).
GluR-B subunit are impermeable to Ca2þ ions and               In addition to Q/R editing sites in GluR-5 and
show a linear current–voltage (I–V ) relationship,         GluR-6 transcripts, two additional adenosines are
whereas channels that lack or contain a nonedited          selectively targeted for modification. Both of these
GluR-B subunit show a double-rectifying I–V rela-          are located in the region encoding the first hydropho-
tionship and an increased Ca2þ conductance                 bic domain (TM1) of GluR-6, and editing leads to the
(Dingledine et al., 1992; Hume et al., 1991).              substitution of a valine (ITT) for a genomically
   The marked functional alterations observed for          specified isoleucine (ATT) codon (I/V site) and the
heteromeric AMPA receptors containing the edited           substitution of a cysteine (TIC) for a tyrosine (TAC)
GluR-B subunit have raised several issues regarding        codon (Y/C site). These editing events provide the
the physiological relevance of this RNA modification.       possibility of eight different edited variants of GluR-6
4
                                                                                                                                                              mRNA Editing
      W V L L G I L H V L F H V A N R L N V M NH2
     Q
      CD I S V S P V A A I
                                   V                                                    NN T
                                     T                                             F V           T
                                             VWP L                               V                 C
                                   D                                                                                                   CN
       K
         F R GGD S T N F I
                                       D
                                          Y           P                         K                   V                             K S      Q
                                                       R                       E                      L                         E            K
      F                              Y
         P                         L                    Y                     E                       N                       C               L
           D                     I                      L                    D                         D                      L               M
           G                   A                       C                    R                          P                     V                  E
           V                   L                      P                     L                         N                      S                 K             Extracellular
     WNQ                       L
                                                                         I G                                                 L                N L L
    S L A P           M P L S                    I WV
                                                                      P I P V                   L V F                I T N I
     I V I               L L V                  V D L S                                       F S G I                                       WV F V
    M I I I           M L V G                    S F L                  V   S V                 F A V                  P  F  F                Y G I
                                                I S A T                I S I G                L P I F                I MW C                 G S C V
     G I T               I A D                                                A                                              L                 P N I
    L I NG                                       L HM                   V   W                  M I T                  V   F
                      MS L A                                          K I A I                                        I V F F                T Y V L
     M I V               Y F L                  S I A C                                       Y T I V                     L G                  F L
                                                                        A I M                                         V
      V A
         S              N                      L                        K                     L                       K                           N          Intracellular
         M              T                     D                        T                     T                      S                           K
          E           A                      R                        R                     I                       A                         I
            K       N                       Y                        S                    Y                            K                        Y R R A   F S N Y L R CNY
              K L H                                                                     V
                                                                                                                          R
                                            V                       N                 L                                N  E                                                K
                                            A                      F                R                         A I N                                       Q R V P P K K E V
                                                                 R             Q
                                                                                  R                G T MQ                                  A V R P I
                                       I/V/M                   S            A                    R                                        A
                                                                     M    L                        P R R E K K K R
                                                             H     L                                                                        T A L S G
                                           R               E     L                                                       R                                R E L N V N I
                                                                                                                            R
                                            N/S/G I/V         H                                                              A                                        Y
                                                   P         G
                                                           H                                                                 N         ND S A K E I       V P E N T HR
                                                                                                                             Q       E
                                                           T                                                                       P
              RNA editing                                 E                                                                 D
                                                                                                                                    G
                                                                                                                          Q            I E MQ V E N       L E L P V
                region                                   E                                                              N                                           N
                                                        P                                                             P                                              P
                                                        P                                                          N                                                S
                                                                                                                 A                HOOC V S S I R          E S V V S
                                                         G                                                     S
                                                           L                                              E N
                                                             S                                       E  E
(a)                                                             L D F L K C C K R N T A
                                       A                                                GA
                                           B         EC              D                 G C
                                                                                       C U
                                                                            U          C   A
         A                A                                                U U         G A          U C        A         UAUU
 A UCGGU UGU A       GC A U A C G U A A U C C U A U U G A G C A U A G C C G C A A U U C C G C C A         A UG AGA UUGC       G
 UGGU C A A C A UG   U G U A U G U A U U A G G A U A A C U C G U A U C G G C G U U A A G C C G G UU       U A U UUUA ACG      U
        G G      C G      C                  C C                           G C         A A        U            C         GGUU
        C A      A A                         U U                            A           AU         U    A
        U C      A A                          U                                                      U G     Exon
         G         C                                                                                 CG
                                                                                                   A A UA   Intron
                                                                                                   A    A
(b)                                                                                                 A A
                                                                                                      U
Figure 3 RNA editing of 5-HT2CR transcripts. (a) Representation of the amino acid sequence and predicted topology of the
human 2C subtype of serotonin receptor. The positions of amino acid alterations in the second intracellular loop of the receptor, which
result from A-to-I editing events, are indicated, along with possible amino acid residues that result from permutations of editing at five
distinct sites. (b) Secondary structure of the region of major editing modifications in the pre-mRNA transcript encoding the 5-HT2CR,
as predicted by RNA folding algorithms (Zuker, 1989); the positions of the five edited adenosine residues (labeled A–E) and the exon–intron
boundary are indicated. The codons altered by RNA editing are emboldened and shaded to match the amino acid positions shown in (a).
                                                                                                                                                                               5
    mRNA Editing
psychiatric and behavioral disorders, including psy-         genes (Venter et al., 2001) – far less than the number
chotic depression, dysthymia, obsessive–compulsive           previously anticipated to support the highly sophisti-
disorder, anxiety and schizophrenia (Dubovsky and            cated biological functions of human beings. Despite
Thomas, 1995; Pandey et al., 1995; Teitler and               this apparent paucity of genes, however, the main
Herrick-Davis, 1994; Julius, 1991). Mutant mice in           focus of the postgenomic era will most likely turn
which expression of the 5-HT2CR has been selectively         toward describing and functionally characterizing
ablated show leptin-independent hyperphagia and              the full complement of proteins (i.e. the proteome)
type 2 diabetes (Nonogaki et al., 1998), death from          that are expressed by an organism. The number of
spontaneous and audiogenic seizures (Applegate and           proteins in the proteome is by no means equivalent to
Tecott, 1998; Brennan et al., 1997; Tecott et al., 1995)     the number of genes itself, but is also dependent on
and learning deficits resulting from hippocampal              numerous cellular strategies that function to increase
dysfunction (Tecott et al., 1998).                           protein diversity, such as DNA recombination,
   RNA transcripts encoding the 5-HT2CR undergo              multiple transcription start sites, alternative pre-
up to five A-to-I editing events (at sites A–E), which        mRNA splicing, RNA editing and posttranslational
predict alterations in the identity of three amino acids     protein modification. (See RNA Processing; Splicing of
in the second intracellular loop of the receptor             pre-mRNA.)
(Figure 3a; Niswender et al., 1999; Burns et al.,                Because most editing events in human mRNAs
1997) – a region involved in coupling to G proteins          have been serendipitously identified on the basis of
(Pin et al., 1994; Wong et al., 1990). Sequence analysis     discrepancies between genomic and cDNA sequences,
of cDNAs isolated from dissected rat and human               it is not necessarily surprising that only a few edited
brains has shown the region-specific expression of as         transcripts have been described so far. With the com-
many as 12 principal 5-HT2C receptor isoforms                pletion of the Human Genome Project, however, our
encoded by 18 distinct RNA species (Niswender et al.,        ability to identify additional edited RNAs, by using
1999; Burns et al., 1997), suggesting that differentially    bioinformatic, genetic and biochemical approaches,
edited 5-HT2C receptors may have distinct biological         should accelerate rapidly. By using such genomic
functions in the regions in which they are expressed. As     sequence information, many A-to-I modified human
with all identified A-to-I editing substrates, the            brain transcripts have been identified already on the
specificity of 5-HT2CR editing results from an RNA            basis of the presence of inosine in the mature mRNAs
duplex region in the 5-HT2CR pre-mRNA formed by              (Morse et al., 2002). Unexpectedly, these newly identi-
base-pairing interactions between exon and intron            fied RNA species contain editing events in noncoding
sequences (Figure 3b; Burns et al., 1997).                   RNAs or noncoding regions of mRNAs, suggesting
   Functional comparisons of the nonedited 5-HT2CR           that RNA editing may influence many aspects of
(containing isoleucine, asparagine and isoleucine at         cellular RNA function. (See 30 UTRs and Regulation;
amino acids 157, 159 and 161 respectively) and the           50 UTRs and Regulation; Noncoding RNAs: A Regulatory
edited 5-HT2CR isoform (containing valine, glycine           Role?)
and valine at the analogous positions) identified a              Although seemingly subtle single-base modifica-
40-fold decrease in serotonergic potency to stimulate        tions in open reading frames can generate multiple
the hydrolysis of phosphoinositides; this decrease in        protein isoforms with distinct biological activities
serotonin potency results from a reduced G-protein           (Gott and Emeson, 2000; Rueter and Emeson, 1998),
coupling efficiency induced by the introduction of            editing events in introns can affect splicing patterns
novel amino acids into the second intracellular loop of      (Rueter et al., 1999; Wissinger et al., 1991) and editing
the receptor (Niswender et al., 1999). Other studies         events in noncoding RNAs or in the 50 and 30
have indicated that alterations in 5-HT2CR editing are       untranslated regions of mRNAs (Morse et al., 2002;
present in individuals diagnosed with schizophrenia          Keller et al., 1999) may modulate processes such as
(Sodhi et al., 2001), as well as in suicide victims with a   RNA stability, localization and translation efficiency.
history of major depression (Gurevich et al., 2002;          The ultimate biological relevance of editing for
Niswender et al., 2001), suggesting that editing of the      human mRNAs resides in the specific RNA transcripts
5-HT2CR may be involved in neuropsychiatric                  that are modified by these processes, and it is
disorders and in the maintenance of appropriate              anticipated that the completed human genome se-
serotonergic signaling.                                      quence will not only serve to identify additional edited
                                                             transcripts, but also to determine the full array of
                                                             cellular processes in which RNA editing has a role.
Perspectives and Future Directions                           (See mRNA Localization: Mechanisms; mRNA Stability
                                                             and the Control of Gene Expression; mRNA Turnover;
Analysis of the completed human genome sequence              RNA Editing and Human Disorders; RNA Processing and
has suggested that it may contain as few as 30 000           Human Disorders.)